Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk.

Swanepoel, Ione; Roberts, April; Brauns, Chelsea; Chaliha, Devahuti R; Papa, Veronica; Palmer, Raymond D; Vaccarezza, Mauro

Swanepoel, Ione; Roberts, April; Brauns, Chelsea; Chaliha, Devahuti R; Papa, Veronica; Palmer, Raymond D; Vaccarezza, Mauro.

Afiliação

Swanepoel I; School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.
Roberts A; School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.
Brauns C; School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.
Chaliha DR; Curtin Health Innovation Research Institute (CHIRI), Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia.
Papa V; Sport Sciences and Wellness, University of Naples Parthenope, Naples, Campania, Italy.
Palmer RD; FAPAB Research Center, Avola, Siracusa, Italy.
Vaccarezza M; Longevity Experts, Helium-3 Biotech, South Perth, Western Australia, Australia.

Postgrad Med J ; 98(1163): 723-727, 2022 Sep.

Article em En | MEDLINE | ID: mdl-33790031

Assuntos

Doenças Cardiovasculares; Doenças Cardiovasculares/prevenção & controle; Fatores de Risco de Doenças Cardíacas; Humanos; Metilaminas/metabolismo; Fatores de Risco

Palavras-chave

adult cardiology; biophysics; coronary heart disease; microbiology; pathology; vascular medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Postgrad Med J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google